Thompson et al. used publicly available RNA sequencing datasets to assess the expression of mucin family members and their splice variants in pancreatic ductal adenocarcinoma and found that patients expressing MUC16 splice variants had shorter survival [25]. This evidence concerns the gene MUC16 and pancreatic ductal adenocarcinoma.